Martingale Asset Management L P Adma Biologics, Inc. Transaction History
Martingale Asset Management L P
- $4.27 Billion
- Q3 2024
A detailed history of Martingale Asset Management L P transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 50,346 shares of ADMA stock, worth $849,337. This represents 0.02% of its overall portfolio holdings.
Number of Shares
50,346
Previous 57,327
12.18%
Holding current value
$849,337
Previous $640,000
57.19%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
326Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$315 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$306 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$219 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$213 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$145 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.31B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...